The 2026 Execution Series
Three decision reports for investors and serious founders navigating beauty, risk, and scale.
Most beauty conversations focus on growth, storytelling, and momentum.
Very few examine what actually breaks beauty businesses after the pitch deck, the raise, or the viral moment.
The Pretty Equity 2026 Execution Series is a three-part set of decision briefs designed to help investors and serious founders identify execution, regulatory, and scale risk before those risks turn into lost capital, stalled growth, recalls, or enforcement exposure.
This series is not designed to teach people how to start a beauty brand. It is designed to help decision-makers understand where confidence often exceeds infrastructure.
Each brief focuses on a different phase of failure that shows up repeatedly in beauty investing and scaling.
Part I
The Beauty Execution Reality Check
What actually breaks beauty brands after the deck—and how to spot it early
The 2026 Execution Series
Part II
The Beauty Due Diligence Gap
Why most diligence misses real risk, and how better questions change outcomes
June 2026
Part III
The Scale Stress Test
What happens when growth outpaces systems, suppliers, and safeguards
October 2026
This series is built for beauty and personal care investors evaluating opportunities, advisors supporting diligence or scale decisions, and founders preparing for capital, retail, or significant growth.